BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Canopus BioPharma, Inc. 

11825 Ventura Boulevard

Studio City  California  91604  U.S.A.
Phone: 818-980-5008 Fax: 818-980-5088


SEARCH JOBS










 Company News
Major Influenza Pandemic Threat is now Preventable and Treatable with Canopus BioPharma, Inc.'s Aerosol Statin Formulation 5/12/2009 10:32:04 AM    More...
Working with U.S. Department of Defense, Canopus BioPharma, Inc. Announces Phase II Human Clinical Trial for Innovative Hepatitis C Drug, CB5300 11/4/2008 9:02:16 AM    More...
Canopus BioPharma, Inc. Announces Positive Results in Human Study of Novel Peptide Cancer Vaccine 11/3/2008 6:31:44 AM    More...
Canopus BioPharma, Inc. and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic 8/12/2008 11:27:23 AM    More...
CB1400, Patented by Canopus BioPharma, Inc., Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck 6/23/2008 7:43:55 AM    More...
B1400, Patented by Canopus BioPharma, Inc., Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux) 6/19/2008 10:08:43 AM    More...
Canopus BioPharma, Inc. Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement with Wisconsin Alumni Research Foundation (WARF) 6/18/2008 10:05:11 AM    More...
Canopus BioPharma, Inc. to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo 5/15/2008 10:15:29 AM    More...
Canopus BioPharma, Inc. Engages Pullan Consulting to Commence the Formation of Drug Development and Licensing Partnerships 5/1/2008 9:34:13 AM    More...
Canopus BioPharma, Inc. Selected to Present its Drug Candidate for HIV/AIDS Treatment at the Global Summit on AIDS and the Church 12/3/2007 11:59:48 AM    More...
12